ω-Conotoxin GVIA

ω-Conotoxin GVIA is a highly selective peptide neurotoxin derived from the venom of the marine cone snail Conus geographus. As a 27-amino acid peptide, it is renowned for its potent and specific inhibition of N-type voltage-gated calcium channels (CaV2.2) in neuronal membranes. This specificity has made ω-Conotoxin GVIA an indispensable tool in neuropharmacology, where it serves as a molecular probe to dissect calcium channel function, synaptic transmission, and neuronal signaling pathways. Its unique structural motif and high affinity for N-type channels underpin its value in both fundamental neuroscience research and advanced pharmacological studies.

Ion Channel Research: In electrophysiological and neurobiological investigations, ω-Conotoxin GVIA is routinely utilized to selectively block N-type calcium channels. This enables researchers to distinguish the physiological roles of different calcium channel subtypes within excitable tissues. By applying the peptide in patch-clamp recordings or synaptosomal preparations, scientists can isolate N-type channel-mediated currents, elucidate their contribution to neurotransmitter release, and parse out complex signaling cascades in neuronal networks.

Synaptic Transmission Studies: The peptide's high specificity for presynaptic N-type calcium channels allows for precise manipulation of synaptic activity. Researchers employ ω-Conotoxin GVIA to inhibit calcium influx at presynaptic terminals, thereby suppressing neurotransmitter release in a controlled manner. This approach is instrumental in mapping synaptic circuitry, characterizing the molecular basis of synaptic plasticity, and investigating the mechanisms underlying synaptic vesicle dynamics in both central and peripheral nervous systems.

Neuropharmacological Screening: As a reference inhibitor of N-type calcium channels, ω-Conotoxin GVIA is widely used in drug discovery and screening platforms. Its well-characterized mode of action provides a benchmark for evaluating the potency and selectivity of novel calcium channel modulators. By comparing candidate compounds to the inhibitory profile of this conotoxin, researchers can rapidly assess pharmacological specificity and guide the optimization of therapeutic leads targeting neuronal calcium channels.

Pain Pathway Mechanism Elucidation: The role of N-type calcium channels in nociceptive signaling has prompted extensive use of ω-Conotoxin GVIA in pain research. By selectively inhibiting these channels, the peptide aids in delineating the molecular mechanisms of pain transmission and modulation within dorsal root ganglion neurons and spinal cord circuits. Such studies enhance the understanding of sensory neuron physiology and facilitate the identification of novel targets for analgesic development in preclinical models.

Peptide Structure-Function Analysis: Owing to its intricate disulfide-bonded conformation, ω-Conotoxin GVIA also serves as a model system for structure-activity relationship (SAR) studies in peptide science. Researchers investigate the effects of sequence modifications, disulfide bond rearrangements, and chemical labeling on channel affinity and selectivity. These studies not only advance the field of peptide engineering but also inform the rational design of next-generation ion channel modulators with improved pharmacological profiles.

1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis